Medicare covers the injectable drug, Reclast, when a doctor deems it medically necessary for the treatment and prevention of osteoporosis. There are specific eligibility criteria, including having ...
The U.S. Food and Drug Administration (FDA) has approved Reclast® (zoledronic acid) Injection, the first and only once-yearly treatment for postmenopausal osteoporosis. Approximately 8 million women ...
Reclast (zoledronic acid) is a medication that the Food and Drug Administration (FDA) has approved for preventing and treating osteoporosis in females after menopause, males, and individuals who take ...
DEAR DR. ROACH: For the last few years, I have been taking yearly Reclast infusions for osteoporosis, because I have trouble taking oral medications of any kind. The infusion was given in February ...
Dear Dr. Roach: I am a 71-year-old woman who still works full-time as a teacher. I have osteoporosis and have had two bone scans. My latest scan showed a slight deterioration from the first two years ...
Reclast provides year-long bisphosphonate compliance with a single infusion. Reclast is the only yearly treatment approved to reduce the risk of fractures in areas of the body typically affected by ...
Q: I am a 71-year-old woman who still works full time as a teacher. I have osteoporosis and have had two bone scans. My latest scan showed a slight deterioration from the first two years ago. My ...
DEAR DR. ROACH: I am a 71-year-old woman who still works full-time as a teacher. I have osteoporosis and have had two bone scans. My latest scan showed a slight deterioration from the first two years ...
Dear Dr. Roach: I have had osteoporosis for a while and recently had a bone density test that again confirmed that I have it. I am not really interested in taking an oral prescription such as Fosamax, ...
Q: For the last few years, I have been taking yearly Reclast infusions for osteoporosis, because I have trouble taking oral medications of any kind. The infusion was given in February 2022, and over ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results